Voravit Ratanatharathorn

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Voravit

Contact Voravit, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.

Claim your profile

Articles

Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation

Jul 19, 2024 |

By Brent R. Logan, Dan Wang, Mary M. Horowitz, Voravit Ratanatharathorn

| tu-dresden.de

Abstract Externe IDs PubMed 19344418 Schlagworte Allogeneic, Graft-versus-host disease, Lymphoma, Rituximab, Transplantation

Open in Who Shared

See all 1 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.

Claim your profile

Get in touch with Voravit

Contact Voravit, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

For PR Teams

Overview

Use Cases

Capabilities

Industries

Introducing Curation Engine

Resources

Library

Commmunity

Customers

Company

Voravit Ratanatharathorn

Get in touch with Voravit

Actions

Is this you?

Articles

Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation

Actions

Is this you?

Get in touch with Voravit